Lord Stone of Blackheath

The Home Office is the lead department for controlled drug legislation, whilst the Department of Health and Social Care and its Arm's Length Bodies lead on healthcare and the regulation of medicines. The Government has no plans to change this.

The Department of Health and Social Care and the Home Office work closely with other system partners in developing and reviewing policy on controlled drugs in healthcare, including cannabis-based products for medicinal use (CBPMs).

The Department of Health and Social Care and NHS England are taking an evidenced-based approach to the access of CBPMs. Since the law changed in 2018 to allow the lawful access to unlicensed CBPMs, two licensed cannabis-based medicines have been made available for prescribing on the National Health Service for patients with multiple sclerosis or hard to treat epilepsies and tuberous sclerosis, where clinically appropriate. This follows approval from the Medicines and Healthcare products Regulatory Agency and the National Institute for Health and Care Excellence (NICE).

NICE has assessed the available evidence, concluding that there is a clear need for more evidence to support routine prescribing and funding decisions of unlicensed CBPMs. NHS funding decisions follow established procedures that ensure equitable distribution of funding, prioritising those medicines that have proved their safety, quality, and clinical and cost effectiveness.

On the 2 June, the Government asked the Advisory Council on the Misuse of Drugs (ACMD), a statutory independent scientific advisory body that advises the Government on drug-related issues, to review the effect of the 2018 law change, and to look at whether it has had the desired impact, and whether there are any unintended consequences. The Government will carefully consider the ACMD’s advice prior to making any decisions.

There are extensive arrangements in place in England to ensure that prescriptions are affordable for everyone. Approximately 89% of prescription items are dispensed free of charge in the community in England, and there are wide range of exemptions from prescription charges already in place for which those with medical conditions may be eligible.

The Department does not make provision for the funding of medicines outside of the National Health Service’s commissioning systems and it remains that the cost of treatments sought privately are the responsibility of patients.

Pricing in the private market is a matter for individual companies and for private providers.

The National Health Service does not intend to support a default plant-based approach to hospital food. The Government and the NHS understand the importance of patients receiving healthy, nutritious, and balanced food, including fruit, vegetables, and proteins. The NHS’ National Standards for Food and Drink encourage the use of healthier, more sustainable menus that include an increased consumption of fruit, vegetables, and fibre.

In April 2024, NHS England launched a drive to recruit armed forces veterans into a range of National Health Service roles. The Step into Health pathway supports members of the armed forces community in connecting to NHS organisations to set up training opportunities, clinical and general work placements, insight days, and application support. More information about the programme is available on the NHS website, in an online only format.

While Treasury Ministers and officials are regularly in contact with lenders on all aspects of their mortgage business to understand their position and current lending conditions, it is important to note that the pricing and availability of mortgages is a commercial decision for lenders in which the Government does not intervene. The rules and regulations that govern mortgage lending are set by regulators that are independent of the Government.

However, the Government recognises the importance of affordability and is committed to building 1.5 million more homes over this Parliament. In the 2025 Spending Review, the Government committed an additional £39 billion to a successor for the Affordable Homes Programme, to be delivered over 10 years starting from 2026-2027. This spending, alongside efforts to reform financial regulation, represent a key part of the Government’s mission to kick start economic growth and support more first-time buyers.

In order to repair the public finances and help raise the revenue required to increase funding for public services, the Government has taken the very difficult decision to increase employer National Insurance.

There are a wide range of factors that the Government needs to consider when introducing new tax reliefs, for example whether these support wider Government objectives, or add disproportionate complexity into the tax system. It is likely that a new relief would have to be paid for, at least in part, by increased taxes for other taxpayers or reducing expenditure on public services.